Gabriela Paz-Bailey1, Eli S Rosenberg1, Kate Doyle1, Jorge Munoz-Jordan1, Gilberto A Santiago1, Liore Klein1, Janice Perez-Padilla1, Freddy A Medina1, Stephen H Waterman1, Carlos Garcia Gubern1, Luisa I Alvarado1, Tyler M Sharp1. 1. From the National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, Centers for Disease Control and Prevention (G.P.-B., K.D.), and the Department of Epidemiology, Emory University (E.S.R.), Atlanta; and the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (J.M.-J., G.A.S., J.P.-P., F.A.M., S.H.W., T.M.S.), and Caduceus Healthcare (L.K.), San Juan, and Ponce University School of Medicine-Saint Luke's Episcopal Hospital Consortium, Ponce (C.G.G., L.I.A.) - all in Puerto Rico.
Abstract
BACKGROUND: To estimate the frequency and duration of detectable Zika virus (ZIKV) RNA in human body fluids, we prospectively assessed a cohort of newly infected participants in Puerto Rico. METHODS: We evaluated samples obtained from 150 participants (including 55 men) in whom ZIKV RNA was detected on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in urine or blood in an enhanced arboviral clinical surveillance site. We collected serum, urine, saliva, semen, and vaginal secretions weekly for the first month and then at 2, 4, and 6 months. All specimens were tested by means of RT-PCR, and serum was tested with the use of anti-ZIKV IgM enzyme-linked immunosorbent assay. Among the participants with ZIKV RNA in any specimen at week 4, biweekly collection continued until all specimens tested negative. We used parametric Weibull regression models to estimate the time until the loss of ZIKV RNA detection in each body fluid and reported the findings in medians and 95th percentiles. RESULTS: The medians and 95th percentiles for the time until the loss of ZIKV RNA detection were 14 days (95% confidence interval [CI], 11 to 17) and 54 days (95% CI, 43 to 64), respectively, in serum; 8 days (95% CI, 6 to 10) and 39 days (95% CI, 31 to 47) in urine; and 34 days (95% CI, 28 to 41) and 81 days (95% CI, 64 to 98) in semen. Few participants had detectable ZIKV RNA in saliva or vaginal secretions. CONCLUSIONS: The prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. Current sexual-prevention guidelines recommend that men use condoms or abstain from sex for 6 months after ZIKV exposure; in 95% of the men in this study, ZIKV RNA was cleared from semen after about 3 months. (Funded by the Centers for Disease Control and Prevention.).
BACKGROUND: To estimate the frequency and duration of detectable Zika virus (ZIKV) RNA in human body fluids, we prospectively assessed a cohort of newly infected participants in Puerto Rico. METHODS: We evaluated samples obtained from 150 participants (including 55 men) in whom ZIKV RNA was detected on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in urine or blood in an enhanced arboviral clinical surveillance site. We collected serum, urine, saliva, semen, and vaginal secretions weekly for the first month and then at 2, 4, and 6 months. All specimens were tested by means of RT-PCR, and serum was tested with the use of anti-ZIKV IgM enzyme-linked immunosorbent assay. Among the participants with ZIKV RNA in any specimen at week 4, biweekly collection continued until all specimens tested negative. We used parametric Weibull regression models to estimate the time until the loss of ZIKV RNA detection in each body fluid and reported the findings in medians and 95th percentiles. RESULTS: The medians and 95th percentiles for the time until the loss of ZIKV RNA detection were 14 days (95% confidence interval [CI], 11 to 17) and 54 days (95% CI, 43 to 64), respectively, in serum; 8 days (95% CI, 6 to 10) and 39 days (95% CI, 31 to 47) in urine; and 34 days (95% CI, 28 to 41) and 81 days (95% CI, 64 to 98) in semen. Few participants had detectable ZIKV RNA in saliva or vaginal secretions. CONCLUSIONS: The prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. Current sexual-prevention guidelines recommend that men use condoms or abstain from sex for 6 months after ZIKV exposure; in 95% of the men in this study, ZIKV RNA was cleared from semen after about 3 months. (Funded by the Centers for Disease Control and Prevention.).
Authors: Tyler M Sharp; Jorge Muñoz-Jordán; Janice Perez-Padilla; Melissa I Bello-Pagán; Aidsa Rivera; Daniel M Pastula; Jorge L Salinas; Jose H Martínez Mendez; Mónica Méndez; Ann M Powers; Stephen Waterman; Brenda Rivera-García Journal: Clin Infect Dis Date: 2016-07-14 Impact factor: 9.079
Authors: Marta Arsuaga; Silvia García Bujalance; Marta Díaz-Menéndez; Ana Vázquez; Jose R Arribas Journal: Lancet Infect Dis Date: 2016-09-19 Impact factor: 25.071
Authors: Sonia Perez; Ruben Tato; Jorge Julio Cabrera; Alberto Lopez; Olga Robles; Eugenio Paz; Amparo Coira; Maria Paz Sanchez-Seco; Ana Vazquez; Raquel Carballo; Carlos Quintas; Anxela Pousa Journal: Euro Surveill Date: 2016-06-16
Authors: Michael P Busch; Steven H Kleinman; Leslie H Tobler; Hany T Kamel; Philip J Norris; Irina Walsh; Jose L Matud; Harry E Prince; Robert S Lanciotti; David J Wright; Jeffrey M Linnen; Sally Caglioti Journal: J Infect Dis Date: 2008-10-01 Impact factor: 5.226
Authors: D Trew Deckard; Wendy M Chung; John T Brooks; Jessica C Smith; Senait Woldai; Morgan Hennessey; Natalie Kwit; Paul Mead Journal: MMWR Morb Mortal Wkly Rep Date: 2016-04-15 Impact factor: 17.586
Authors: Jonathan S Gootenberg; Omar O Abudayyeh; Jeong Wook Lee; Patrick Essletzbichler; Aaron J Dy; Julia Joung; Vanessa Verdine; Nina Donghia; Nichole M Daringer; Catherine A Freije; Cameron Myhrvold; Roby P Bhattacharyya; Jonathan Livny; Aviv Regev; Eugene V Koonin; Deborah T Hung; Pardis C Sabeti; James J Collins; Feng Zhang Journal: Science Date: 2017-04-13 Impact factor: 47.728
Authors: Emilio Dirlikov; Chelsea G Major; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge L Muñoz-Jordan; Candimar Colon-Sanchez; Myriam Garcia; Marangely Olivero-Segarra; Graciela Malave; Gloria M Rodríguez-Vega; Dana L Thomas; Stephen H Waterman; James J Sejvar; Carlos A Luciano; Tyler M Sharp; Brenda Rivera-García Journal: JAMA Neurol Date: 2018-09-01 Impact factor: 18.302
Authors: Tereza Magalhaes; Brian D Foy; Ernesto T A Marques; Gregory D Ebel; James Weger-Lucarelli Journal: Virus Res Date: 2017-07-11 Impact factor: 3.303
Authors: Chantal B E M Reusken; Marjolein Knoester; Corine GeurtsvanKessel; Marion Koopmans; Daan G Knapen; Wouter F W Bierman; Suzan Pas Journal: J Clin Microbiol Date: 2017-08-30 Impact factor: 5.948
Authors: Chad S Clancy; Arnaud J Van Wettere; Venkatraman Siddharthan; John D Morrey; Justin G Julander Journal: Am J Pathol Date: 2018-01-31 Impact factor: 4.307